Saakshi Medtech & Panels Ltd
General Industrials | Small Cap
Saakshi Medtech & Panels Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation and efficient management of resources in these areas. Its liquidity position is reasonably good but with some concerns in cash flow. However, efficiency and growth metrics reveal significant weaknesses. The company's ability to generate revenue and profits has declined recently, and its turnover ratios suggest challenges in managing assets and inventory. While the company is managing its debts well and achieving good profits, revenue and profit growth need to be improved for better financial health. The financial ratios, including EPS and capital expenditure, need to be improved for long-term sustainability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsOvervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.80
- Financial Ratio2.40
- Profitability Ratio10.00
- Efficiency Ratio3.33
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio7.96
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Saakshi Medtech & Panels Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation and efficient management of resources in these areas. Its liquidity position is reasonably good but with some concerns in cash flow. However, efficiency and growth metrics reveal significant weaknesses. The company's ability to generate revenue and profits has declined recently, and its turnover ratios suggest challenges in managing assets and inventory. While the company is managing its debts well and achieving good profits, revenue and profit growth need to be improved for better financial health. The financial ratios, including EPS and capital expenditure, need to be improved for long-term sustainability.
Overall Valuation Score
P/E RATIO (TTM)
41.89
Industry Median
29.52
Small Cap Median
29.52
P/E RATIO
70.13
P/B RATIO
3.16
Industry Median
2.44
Small Cap Median
2.44
P/S RATIO
3.59
Industry Median
1.94
Small Cap Median
1.94
Others
PEG RATIO
-17.36
EV/EBITDA RATIO
30.13
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹187.25 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company's growth ratios present many challenges. Negative revenue, operating profit, EPS, and net income growth rates indicate a decline in financial performance. While the asset growth rate is positive, the other negative growth rates raise concerns about the company's ability to sustain and expand its business. The company needs to address the underlying issues affecting its growth and profitability to ensure long-term success.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 53.33 | 32.61 | 0 | -24.59 | 26.09 |
| Operating Profit Growth Rate | 166.67 | 31.25 | -4.76 | -50 | 120 |
| Earnings Per Share (EPS) Growth | -58.35 | 160.67 | |||
| Asset Growth Rate | 16.07 | 43.08 | 40.86 | 0 | 19.85 |
| Net Income Growth Rate | 350 | 33.33 | -8.33 | -54.55 | 140 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios highlight areas needing attention. Low adjusted EPS, cash EPS, and book value per share indicate poor financial performance and reduced shareholder value. The company does not pay dividends. High capital expenditures may indicate investments in growth, but their effectiveness needs to be monitored. The company needs to focus on improving its financial performance.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 30 | 40 | 6.11 | 2.78 | 6.67 |
| Cash Earnings Per Share (Cash EPS) | 36.67 | 50 | 8.33 | 5 | 9.44 |
| Book Value Per Share | 100 | 143.33 | 52.22 | 54.44 | 61.67 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | ||
| Capital Expenditures (CapEx) | 5.8 | 11 | 31.7 | 15.2 | 25.4 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company exhibits strong profitability. High gross profit margin, ROCE, ROE, ROA, operating margin, and net margin indicate efficient operations and effective management. These ratios demonstrate the company's ability to generate profits from its sales and assets. The company is performing well in terms of profits and returns.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 15.22 | 14.75 | 13.11 | 6.52 | 14.66 |
| Return on Capital Employed (ROCE) | 32 | 33 | 19 | 6 | 14 |
| Return on Equity (ROE) | 30 | 27.91 | 11.7 | 5.1 | 10.81 |
| Return on Assets (ROA) | 24.62 | 22.58 | 15.27 | 7.63 | 14.01 |
| Operating Margin | 17.39 | 17.21 | 16.39 | 10.87 | 18.97 |
| Net Margin | 9.78 | 9.84 | 9.02 | 5.43 | 10.34 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios indicate areas of concern for the company. Low fixed asset and capital turnover ratios suggest that the company is not efficiently utilizing its assets to generate revenue. High days sales in inventory and receivable days indicate challenges in managing inventory and collecting payments from customers. While the receivables turnover ratio is average, overall efficiency needs to be improved to optimize asset utilization and cash flow. The company needs to improve its asset management.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 3.54 | 3.59 | 1.97 | 1.53 | 1.4 |
| Inventory Turnover Ratio | 6.52 | 5.62 | 4.68 | 4.09 | 4.69 |
| Receivables Turnover Ratio | 5.72 | 6.04 | 6.06 | 4.7 | 4.82 |
| Days Sales in Inventory Ratio | 55.98 | 64.95 | 77.99 | 89.24 | 77.83 |
| Receivable Days | 63.81 | 60.43 | 60.23 | 77.66 | 75.73 |
| Capital Turnover Ratio | 2.47 | 2.43 | 1.12 | 0.82 | 0.91 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios provide a mixed view of the company's ability to meet its financial obligations. The interest coverage ratio indicates a strong ability to cover interest expenses, suggesting low risk related to debt. The equity dividend coverage ratio is low, as company is not paying dividends. The company is able to meet its interest obligations comfortably.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 14 | 18 | 8.5 | N/A | 18 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency ratios indicate a strong financial position. Low debt levels relative to equity and assets suggest that the company is not overly reliant on borrowing. High equity ratio indicates a solid capital base. This ensures long-term financial stability and reduces the risk of financial distress. The company's conservative approach to debt management enhances its resilience to economic downturns.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.19 | 0.14 | 0.14 | 0.13 | 0.13 |
| Debt to Equity Ratio | 0.23 | 0.16 | 0.16 | 0.15 | 0.15 |
| Equity Ratio | 0.81 | 0.86 | 0.86 | 0.87 | 0.87 |
| Debt To Asset Ratio | 0.11 | 0.08 | 0.11 | 0.11 | 0.1 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position of the company reveals strengths and weaknesses. The current and quick ratios suggest a good ability to meet short-term obligations. However, the cash ratio indicates a lower proportion of liquid assets, and the operating cash flow ratio is weak, indicating potential difficulties in generating cash from operations. While the company has enough short-term assets to cover its liabilities, it needs to improve its cash management and operational efficiency to ensure smooth cash flow.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.38 | 1.35 | 3.09 | 3.09 | 2.11 |
| Quick Ratio | 0.91 | 0.81 | 2.11 | 2 | 1.41 |
| Cash Ratio | 0.05 | 0.07 | 0.71 | 0.17 | 0.06 |
| Operating Cash Flow Ratio | 0.39 | 0.25 | 0.36 | 0.16 | 0.59 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Aaron Industries Ltd | 7.80 | 37.65 | Overvalued | 17.69 | 3.25 | 6.80 |
| 2 | Jay Bee Laminations Ltd | 7.33 | 10.31 | Highly Undervalued | 34.00 | 8.09 | 18.00 |
| 3 | Ducon Infratechnologies Ltd | 7.27 | 8.43 | Neutral | 27.00 | 0.09 | 11.00 |
| 4 | Aartech Solonics Ltd | 7.01 | 39.57 | Overvalued | 6.14 | 1.10 | 3.97 |
| 5 | Shivalic Power Control Ltd | 6.55 | 14.86 | Highly Undervalued | 19.00 | 4.28 | 13.00 |
| 6 | Saakshi Medtech & Panels Ltd | 6.38 | 70.13 | Overvalued | 22.00 | 6.96 | 12.00 |
The management effectiveness of Saakshi Medtech & Panels Ltd. is assessed as mixed. A stable promoter holding indicates sustained confidence. However, declining profit growth, decreasing OPM, and increasing cash conversion cycle raise concerns about operational efficiency and profitability. Revenue growth challenges and decreased ROCE further contribute to a cautious outlook.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Promoter Holding | 73.63% | Stable and consistent promoter confidence |
| CONS | Profit Growth | Compounded Profit Growth (3Y: -20%, TTM: -58%) | Declining profit growth |
| Operating Profit Margin (OPM) | OPM decreased from 16.85% (Mar 2023) to 7.94% (Mar 2025) | Decreasing operational efficiency |
Financial Performance & Growth
The financial performance of Saakshi Medtech & Panels Ltd. shows concerning trends in sales and profit growth. The compounded sales growth is 0% over the past 3 years and -24% TTM, indicating revenue expansion challenges. Similarly, the compounded profit growth is -20% over the past 3 years and a significant -58% TTM, reflecting declining profitability. The YOY Sales Growth % has decreased from 33.26% in Mar 2023 to -24.15% in Mar 2025. OPM has declined from 17.34% in Mar 2023 to 7.94% in Mar 2025. These indicators suggest significant challenges in maintaining both sales and profit margins.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Compounded Sales Growth (3Y) | 0% | 0% | 0% |
| Compounded Sales Growth (TTM) | -24% | -24% | -24% |
| Compounded Profit Growth (3Y) | -20% | -20% | -20% |
| Compounded Profit Growth (TTM) | -58% | -58% | -58% |
| YOY Sales Growth % | 33.26% | -0.15% | -24.15% |
| OPM % (Mar) | 17.34% | 16.66% | 7.94% |
Capital Efficiency & Returns
The capital efficiency of Saakshi Medtech & Panels Ltd. is exhibiting concerning trends. The ROCE has significantly decreased from 33.26% in Mar 2023 to 6.16% in Mar 2025, indicating a decline in the company's ability to generate returns from its capital employed. The Cash Conversion Cycle has increased from 84.02 days in Mar 2023 to 210.64 days in Mar 2025, suggesting worsening working capital management and longer periods to convert investments into cash. These factors collectively indicate poor capital efficiency and reduced profitability.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| ROCE % | 33.26% | 19.19% | 6.16% |
| Cash Conversion Cycle (Days) | 84.02 | 109.85 | 210.64 |
Financial Health & Prudence
Saakshi Medtech & Panels Ltd. showcases an average financial health profile based on the available data. The debt management appears stable with borrowings slightly decreasing from ₹20.07 Cr in Mar 2023 to ₹17.83 Cr in Mar 2025. The company has maintained a consistent dividend payout of 0.00% over the observed period, indicating a strategy of reinvesting profits rather than distributing them to shareholders.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Borrowings (Cr) | 20.07 | 18.02 | 17.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
Strategic & Operational Indicators
Saakshi Medtech & Panels Ltd. shows mixed strategic and operational indicators. The Debtor Days have fluctuated, with a noticeable increase to 86.40 days in Mar 2025. Inventory Days have increased from 108.81 days in Mar 2023 to 128.98 days in Mar 2025, indicating slower inventory turnover. Payables Days have significantly decreased from 93.46 days in Mar 2023 to just 4.74 days in Mar 2025, suggesting quicker payment to suppliers. The increase in Inventory Days and Debtor Days, coupled with the decrease in Payables Days, highlight potential inefficiencies in working capital management.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 68.67 | 51.85 | 86.40 |
| Inventory Days | 108.81 | 101.38 | 128.98 |
| Payables Days | 93.46 | 43.37 | 4.74 |
Saakshi Medtech & Panels Ltd. exhibits a moderate risk profile. Declining segment performance, evidenced by reduced profit margins and ROCE, presents a significant risk. The company's accounting quality and regulatory compliance costs require careful monitoring. These factors collectively contribute to an overall risk assessment.
Segment performance volatility
The segment performance of Saakshi Medtech & Panels Ltd. shows volatility and a concerning decline. Operating Profit Margin (OPM) has decreased from 17.34% in Mar 2023 to 7.94% in Mar 2025, indicating reduced profitability. The ROCE % has also declined substantially from 33.26% in Mar 2023 to 6.16% in Mar 2025, reflecting lower returns on capital employed. This variability indicates instability in segment performance.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| OPM % | 17.34% | 16.66% | 7.94% |
| ROCE % | 33.26% | 19.19% | 6.16% |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe